In a retrospective analysis involving prostate cancer patients receiving androgen deprivation therapy, findings revealed that among the 65 patients with bone metastases who underwent 68Ga-PSMA PET/CT scans, 15 individuals (23%) displayed a decrease in the density of their bone metastases. This evidence concerns the gene FOLH1 and prostate carcinoma.